Literature DB >> 21292877

Immune responses and protection of Aotus monkeys immunized with irradiated Plasmodium vivax sporozoites.

Alejandro Jordán-Villegas1, Anilza Bonelo Perdomo, Judith E Epstein, Jesús López, Alejandro Castellanos, María R Manzano, Miguel A Hernández, Liliana Soto, Fabián Méndez, Thomas L Richie, Stephen L Hoffman, Myriam Arévalo-Herrera, Sócrates Herrera.   

Abstract

A non-human primate model for the induction of protective immunity against the pre-erythrocytic stages of Plasmodium vivax malaria using radiation-attenuated P. vivax sporozoites may help to characterize protective immune mechanisms and identify novel malaria vaccine candidates. Immune responses and protective efficacy induced by vaccination with irradiated P. vivax sporozoites were evaluated in malaria-naive Aotus monkeys. Three groups of six monkeys received two, five, or ten intravenous inoculations, respectively, of 100,000 irradiated P. vivax sporozoites; control groups received either 10 doses of uninfected salivary gland extract or no inoculations. Immunization resulted in the production low levels of antibodies that specifically recognized P. vivax sporozoites and the circumsporozoite protein. Additionally, immunization induced low levels of antigen-specific IFN-γ responses. Intravenous challenge with viable sporozoites resulted in partial protection in a dose-dependent manner. These findings suggest that the Aotus monkey model may be able to play a role in preclinical development of P. vivax pre-erythrocytic stage vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292877      PMCID: PMC3032489          DOI: 10.4269/ajtmh.2011.09-0759

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  43 in total

1.  Immunity to sporozoite-induced malaria infeciton in mice. I. The effect of immunization of T and B cell-deficient mice.

Authors:  D H Chen; R E Tigelaar; F I Weinbaum
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

2.  Specificity of protection of man immunized against sporozoite-induced falciparum malaria.

Authors:  D F Clyde; V C McCarthy; R M Miller; R B Hornick
Journal:  Am J Med Sci       Date:  1973-12       Impact factor: 2.378

3.  Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity.

Authors:  R Nussenzweig; J Vanderberg; H Most
Journal:  Mil Med       Date:  1969-09       Impact factor: 1.437

4.  Studies on the transfer of protective immunity with lymphoid cells from mice immune to malaria sporozoites.

Authors:  J P Verhave; G T Strickland; H A Jaffe; A Ahmed
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

Review 5.  Aotus monkeys: their great value for anti-malaria vaccines and drug testing.

Authors:  Sócrates Herrera; Blanca Liliana Perlaza; Anilza Bonelo; Myriam Arévalo-Herrera
Journal:  Int J Parasitol       Date:  2002-12-04       Impact factor: 3.981

6.  Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei.

Authors:  R S Nussenzweig; J Vanderberg; H Most; C Orton
Journal:  Nature       Date:  1967-10-14       Impact factor: 49.962

7.  Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites.

Authors:  R W Gwadz; A H Cochrane; V Nussenzweig; R S Nussenzweig
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

8.  A strain of Plasmodium vivax characterized by prolonged incubation: the effect of numbers of sporozoites on the length of the prepatent period.

Authors:  P G Shute; G Lupascu; P Branzei; M Maryon; P Constantinescu; L J Bruce-Chwatt; C C Draper; R Killick-Kendrick; P C Garnham
Journal:  Trans R Soc Trop Med Hyg       Date:  1976       Impact factor: 2.184

9.  Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.

Authors:  D F Clyde
Journal:  Am J Trop Med Hyg       Date:  1975-05       Impact factor: 2.345

Review 10.  Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine.

Authors:  Thomas C Luke; Stephen L Hoffman
Journal:  J Exp Biol       Date:  2003-11       Impact factor: 3.312

View more
  6 in total

Review 1.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

2.  Antibody Profiling by Proteome Microarray with Multiplex Isotype Detection Reveals Overlap between Human and Aotus nancymaae Controlled Malaria Infections.

Authors:  Omid Taghavian; Aarti Jain; Chester J Joyner; Sunny Ketchum; Rie Nakajima; Algis Jasinskas; Li Liang; Rich Fong; Christopher King; Bryan Greenhouse; Maxwell Murphy; Jason Bailey; Mary R Galinski; John W Barnwell; Christopher V Plowe; D Huw Davies; Philip L Felgner
Journal:  Proteomics       Date:  2018-01       Impact factor: 3.984

3.  Protective Efficacy of Plasmodium vivax Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial.

Authors:  Myriam Arévalo-Herrera; Juan M Vásquez-Jiménez; Mary Lopez-Perez; Andrés F Vallejo; Andrés B Amado-Garavito; Nora Céspedes; Angélica Castellanos; Karen Molina; Johanna Trejos; José Oñate; Judith E Epstein; Thomas L Richie; Sócrates Herrera
Journal:  PLoS Negl Trop Dis       Date:  2016-10-19

4.  Systematic evaluation of monoclonal antibodies and immunoassays for the detection of Interferon-γ and Interleukin-2 in old and new world non-human primates.

Authors:  Ankie Höglind; Irene Areström; Cecilia Ehrnfelt; Khosro Masjedi; Bartek Zuber; Luis Giavedoni; Niklas Ahlborg
Journal:  J Immunol Methods       Date:  2016-11-24       Impact factor: 2.303

5.  Igh locus structure and evolution in Platyrrhines: new insights from a genomic perspective.

Authors:  Diego Garzón-Ospina; Sindy P Buitrago
Journal:  Immunogenetics       Date:  2019-12-14       Impact factor: 2.846

6.  Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.

Authors:  Karolis Bauza; Tomas Malinauskas; Claudia Pfander; Burcu Anar; E Yvonne Jones; Oliver Billker; Adrian V S Hill; Arturo Reyes-Sandoval
Journal:  Infect Immun       Date:  2013-12-30       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.